← FDA Drug Approvals (Drugs@FDA)

AKYNZEO

NDA · New Drug Application · Sponsor: HELSINN HLTHCARE · Approved 2014-10-10

Drug application

FDA Application #

NDA205718

Application type

New Drug Application

Brand name

AKYNZEO

Generic name

NETUPITANT AND PALONOSETRON

Active ingredients

NETUPITANT; PALONOSETRON HYDROCHLORIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

HELSINN HLTHCARE

Manufacturer

Helsinn Therapeutics (U.S.), Inc.

First approval

2014-10-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown